What a fresh method-validation file actually contains for a Tier-1 SFSL toxicology unit.
A state FSL toxicology unit purchases a new LC-MS/MS instrument (Agilent 6470 triple quadrupole) and decides to validate a method for amphetamine, methamphetamine, MDA, MDMA and MDEA in urine. The reference standards are Sigma certified solutions; the deuterated internal standards are d5-amphetamine, d5-methamphetamine, d5-MDA, d5-MDMA and d5-MDEA, all spiked at 50 ng/mL into every sample.
Sample preparation: 0.5 mL urine plus IS cocktail, alkalinised with carbonate buffer to pH 9.5, loaded onto an Oasis MCX SPE cartridge, washed with 1 mL of 0.1 M HCl and 1 mL of methanol, eluted with 2 mL of 5 percent ammonium hydroxide in methanol, evaporated under nitrogen at 35 °C and reconstituted in 100 μL of 95:5 water:acetonitrile with 0.1 percent formic acid. Final injection volume 5 μL.
Linearity: a seven-point calibration curve is built from 1, 5, 10, 25, 50, 100 and 250 ng/mL standards in blank urine. Each point is run in triplicate over three days. R² across all five analytes is between 0.997 and 0.999. Back-calculated concentrations of each calibrator agree with the nominal value within ±10 percent at all concentrations except 1 ng/mL (the LOQ candidate), where ±18 percent is observed. LOQ is set at 1 ng/mL for all five analytes. LOD is calculated from the 3σ method using ten blank-urine injections and lands between 0.2 and 0.4 ng/mL for the five analytes.
Accuracy and precision: spiked QC samples at 3, 15 and 75 ng/mL are run six times within day and on five separate days. Intra-day RSD is between 4 and 9 percent; inter-day RSD is between 6 and 12 percent. Accuracy as percentage recovery is 92 to 105 percent across all three concentrations and all five analytes. Specificity is verified by injecting blank urine from ten drug-free volunteers; no peak appears at any analyte's retention time and MRM transition. Robustness is checked by varying mobile phase pH (3.0 ±0.1), column temperature (40 ±2 °C) and flow rate (0.4 ±0.02 mL/min); the result shifts by less than 5 percent in every condition.
Recovery from real matrix: 0.5 mL aliquots of blank urine are spiked at 5, 25 and 100 ng/mL of each analyte, processed through the full extraction and analysed against an in-solvent calibration curve; recovery is 85 to 96 percent across all five analytes. Carry-over: a blank injection following the 250 ng/mL calibrator shows no peak above 15 percent of the 1 ng/mL LOQ for any analyte; the carry-over criterion (less than 20 percent of LOQ) is satisfied.
The method is signed off by the technical manager, the validation file is filed in the laboratory quality management system with the calibration curve plots, the QC charts, the CRM certificates, the IS certificates, the instrument qualification records and the analyst training records. NABL is notified of the new method scope addition. The first case sample is run six weeks later. The method, the CRM batch number and the calibration date go into the chemical examiner's certificate that is tendered to the magistrate under Bharatiya Sakshya Adhiniyam Section 63. The defence inspects the validation file on application; the file holds. This is what a defensible forensic toxicology method actually looks like.